Skip to main content

Understanding Schizophrenia and Drug Use in New Jersey

Treatment for Schizophrenia and Drug Use in New Jersey

In general, schizophrenia impacts about 1% of adults, but that impact is quickly multiplied when you factor in drugs or alcohol worsening the condition.[1] It’s also more likely for someone with a psychotic disorder to end up in the hospital for crises relating to substance use or addiction than for someone without.

Mental health disorders such as schizophrenia can easily fuel co-occurring addiction to the point of causing homelessness, jail time, and even suicide risk. To effectively treat dual diagnosis, care that addresses both schizophrenia and substance misuse concurrently is needed. Centers that address only schizophrenia without treating addiction are only treating half of the problem. This allows the other half to go unaddressed, or worse. In either case, there is little hope for general wellness for the patient unless they receive integrated mental health and addiction treatment.

Spot the early warning signs in yourself and your loved ones, and connect with evidence-based help that treats both conditions simultaneously.

Is There a Problem with Schizophrenia and Drug Use in New Jersey?

Schizophrenia can create substantial distortions in the perception of reality by the patient. When substance use or alcohol use is piled onto that condition, the confusion can ramp up quickly. Research from the NIDA shows that individuals with serious mental illness, like Schizophrenia, are more likely to develop behavioral health issues like substance use disorders than the general public.[2]

One of the most common drivers is self-medication, since cannabis or alcohol seems to calm the noisy thoughts, but often worsens the underlying psychosis over time. Brain chemistry overlap also has a vital role in this. Both psychotic episodes and drug highs cause dopamine to flood the reward centers, so each problem ends up reinforcing the other.

While this isn’t unique to New Jersey, the combination of severe mental illness and substance use disorders is increasing in prevalence. Data from 2022 shows that 59% of New Jersey adults who attended treatment were diagnosed with a co-occurring disorder.[3]

Opioid misuse is another incredibly complicating factor, and adults with schizophrenia are disproportionately more likely to be represented in an opioid-related ER visit.[4] Cocaine and meth are also known to cause dangerous spikes in paranoia and severe disruptions in sleep hygiene that can intensify existing symptoms or mimic symptoms that aren’t actually present.

Even prescription sleep aids taken without medical guidance may lead to dangerous interactions with antipsychotic medications.

Understanding these links helps families and providers choose treatments that address both conditions together rather than chasing symptoms one at a time.

It can be challenging to recognize schizophrenia in someone with a substance use problem, since they often look similar. Intervention is essential, so keep your eyes peeled for some of the following red flags:

Hallucinations grow louder or more frequent after periods of drinking or using drugs.

Neglected basics such as missed meals, unpaid bills, or skipped hygiene that worsen once substances enter the picture.

Social withdrawal followed by sudden anger or paranoia when someone questions drug use.

Combining prescription antipsychotics with opioids, alcohol, or cannabis despite clear warnings.

Legal or work trouble, including recent arrests, write-ups, or vehicle accidents linked to substance exposure.

Substance Abuse & Schizophrenia Treatment Options

Addressing schizophrenia and drug use in New Jersey means treating two conditions that keep tugging on each other. The best programs integrate psychiatry, addiction medicine, and social support, ensuring that no aspect is overlooked.

Before you can do anything, you’ll need to get a complete medical and psychiatric evaluation at the treatment center of your choice. This includes emergency departments, community behavioral health centers, and private treatment programs. They all perform critical intake assessments that screen for things like psychosis severity, substance use profile, withdrawal danger potential, and general health.

Depending on your unique needs, you may participate in one or more of the following treatments or programs.

Therapies and Medication Management

Evidence-based treatment programs include blocks within their programming for a wide range of evidence-based therapeutic modalities, such as cognitive behavioral therapy, dialectical behavior therapy, acceptance and commitment therapy, and others. There are also blocks that incorporate life skills, such as cooking, budgeting, and stress tolerance.

Medication management is also provided to individuals living with schizophrenia. Psychiatrists will help monitor and maintain prescriptions for antipsychotics to help even out mood fluctuations and overall perception. For clients who are also struggling with alcohol or opioid cravings from AUD or OUD, they may also be given medications like buprenorphine or naltrexone that can be added without worrying about interference with medication for schizophrenia treatment.[5] Regular, ongoing checkups will catch side effects and symptom spikes early, allowing them to be handled accordingly.

Specialty treatments are utilized to cater to the unique requirements of every individual during their recovery:

Executive Program
Vivitrol Treatment
Aftercare
Trauma-Informed Care
Dual Diagnosis
Recovery Capital
Alumni Services
Sober Living

Levels of Care for Schizophrenia and Addiction

Leading Treatment for Schizophrenia and Drug Use in New Jersey

Contact Admissions Today

Can I use antipsychotics with buprenorphine or naltrexone?

Does Medicaid pay for dual-diagnosis care for schizophrenia and addiction?

Who can I call for addiction crises in the middle of the night?

Sources

[1] Tac. (2025, March 10). Schizophrenia fact sheet – Treatment Advocacy Center. Treatment Advocacy Center -. https://www.tac.org/reports_publications/schizophrenia-fact-sheet/

[2]U.S. Department of Health and Human Services. (2024, October 3). Co-occurring disorders and health conditions. National Institutes of Health. https://nida.nih.gov/research-topics/co-occurring-disorders-health-conditions#problems-occur

[3]Substance use overview 2022 statewide – nj.gov. (n.d.). https://www.nj.gov/humanservices/dmhas/publications/statistical/Substance%20Abuse%20Overview/2022/Statewide.pdf

[4]Winklbaur, B., Ebner, N., Sachs, G., Thau, K., & Fischer, G. (2006). Substance abuse in patients with schizophrenia. Dialogues in clinical neuroscience. https://pmc.ncbi.nlm.nih.gov/articles/PMC3181760/

[5]El Hayek SA;Shatila MA;Adnan JA;Geagea LE;Kobeissy F;Talih FR; (n.d.). Is there a therapeutic potential in combining bupropion and naltrexone in schizophrenia?. Expert review of neurotherapeutics. https://pubmed.ncbi.nlm.nih.gov/36093756/

[6]Scannell, C. (2021, October 13). Voices of hope: Substance use peer support in a system of care. Substance abuse : research and treatment. https://pmc.ncbi.nlm.nih.gov/articles/PMC8524681/